Abstract
195 - Letermovir Use for Primary and Secondary Prophylaxis and Pre-Emptive Therapy to Prevent Cytomegalovirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation: A Single Bone Marrow Transplant Center Quality Improvement Initiative
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
